©The Author(s) 2025.
World J Psychiatry. Oct 19, 2025; 15(10): 101658
Published online Oct 19, 2025. doi: 10.5498/wjp.v15.i10.101658
Published online Oct 19, 2025. doi: 10.5498/wjp.v15.i10.101658
Figure 4 Scale scores for treatment outcomes in the schizophrenia intervention and control groups.
Positive and negative syndrome scale (PANSS) scores before and after treatment in the intervention and control groups. A: Negative factor score; B: Positive factor score; C: General psychopathology score; D: Total PANSS score; E: Scale for the assessment of negative symptoms scores for treatment outcomes in the schizophrenia intervention and control groups (intervention group = 48 cases, control group = 49 cases). 1Indicates a significant difference compared to the control group; 2Indicates a significant difference before and after the intervention; aP < 0.05. NS: Not significance; PANSS: Positive and negative syndrome scale; SANS: Scale for the assessment of negative symptoms.
- Citation: Zhu DM, Lu Y, Xiao XD, Sun Y, Tao G, Long B, Zhao J. Enhancing schizophrenia treatment efficacy: The combined impact of Yueju pill and olanzapine through quercetin target modulation. World J Psychiatry 2025; 15(10): 101658
- URL: https://www.wjgnet.com/2220-3206/full/v15/i10/101658.htm
- DOI: https://dx.doi.org/10.5498/wjp.v15.i10.101658